CDK4/6 inhibitor combination could overcome drug resistance in advanced prostate cancer
With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent cancer and the fifth leading cause of cancer death among men in 2022. Hormone therapy based on the ...
Jul 22, 2025
0
21









